GE HealthCare Technologies Inc. (GEHC)

Market Cap	36.61B -10.5%
Revenue (ttm)	20.63B +4.8%
Net Income	2.08B +4.6%
EPS	4.55 +4.8%
Shares Out	455.75M
PE Ratio	17.66
Forward PE	15.97
Dividend	$0.14 (0.17%)
Ex-Dividend Date	Jan 9, 2026

Volume	5,624,492
Open	78.65
Previous Close	78.65
Day's Range	78.48 - 82.09
52-Week Range	57.65 - 94.80
Beta	1.23
Analysts	Buy
Price Target	91.17 (+13.48%)
Earnings Date	Feb 4, 2026

About GEHC

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1892
• Employees: 54,000
• Stock Exchange: NASDAQ
• Ticker Symbol: GEHC
• Website: https://www.gehealthcare.com

Financial Performance

In 2025, GEHC's revenue was $20.63 billion, an increase of 4.84% compared to the previous year's $19.67 billion. Earnings were $2.08 billion, an increase of 4.57%.

Analyst Summary

According to 12 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price target is $91.17, which is an increase of 13.48% from the latest price.

Price Target

$91.17

(13.48% upside)

Analyst Consensus: Buy